Identification of HOXC4 as A Potential Drug Target (G3221)

Target Name: HOXC4

NCBI ID: G3221

HOXC4

Identification of HOXC4 as A Potential Drug Target

Homeobox proteins (Hoxes) are a family of transcription factors that play a crucial role in the regulation of gene expression. Hoxes are named after the protein subunit encoded by the HOX gene, which is located on chromosome 2. Hox genes are involved in the development, growth, and maintenance of tissues and organs, as well as in the regulation of various cellular processes.

One of the well-known Hox proteins is CP19 (homeobox protein 19), which is a protein that is expressed in various tissues and organs, including brain, heart, and muscle. It is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

HOXCP19: A Potential Drug Target

HOXCP19 is a protein that has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions and interactions with other molecules make it an attractive target for drug development.

Disease-Related HoxCP19 Expression

HoxCP19 is involved in the regulation of various cellular processes that are implicated in the development and progression of various diseases. For example, it is involved in the regulation of cell growth and differentiation, which are crucial for the development of tissues and organs. It is also involved in the regulation of cell survival and apoptosis, which are crucial for the regulation of tissue homeostasis.

In neurodegenerative diseases, HoxCP19 has been implicated in the development and progression of diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Studies have shown that HoxCP19 is involved in the regulation of neurotransmitter signaling systems, which are crucial for the function of neurons.

In cancer, HoxCP19 has been shown to be involved in the regulation of cell proliferation and survival. It is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in tumors.

HOXCP19 Interactions with Other Molecules

HOXCP19 interacts with various molecules, including transcription factors, DNA-binding proteins, and RNA-binding proteins. It has been shown to interact with factors such as p53, a protein that is involved in the regulation of cellular processes such as apoptosis.

HOXCP19 has also been shown to interact with proteins involved in the regulation of cellular processes such as cell growth and differentiation, including factors such as TGF-尾1 and Wnt. It has also been shown to interact with proteins involved in the regulation of ion channels, including Ca2+ channels.

Conclusion

HOXCP19 is a protein that is involved in various cellular processes that are crucial for the development and progression of diseases. Its functions and interactions with other molecules make it an attractive target for drug development. Further research is needed to fully understand the role of HoxCP19 in the regulation of cellular processes and its potential as a drug target.

Protein Name: Homeobox C4

Functions: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

The "HOXC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets